Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.8569
+0.0335 (4.07%)
At close: May 18, 2026, 4:00 PM EDT
0.8251
-0.0318 (-3.71%)
After-hours: May 18, 2026, 4:00 PM EDT
Aptorum Group Employees
Aptorum Group had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,363,270
Market Cap
6.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| TransCode Therapeutics | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
APM News
- 2 months ago - Aptorum Group, DiamiR announce publication of microRNA biomarker study - TheFly
- 2 months ago - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - GlobeNewsWire
- 2 months ago - Aptorum Group receives noncompliance notification from Nasdaq - TheFly
- 3 months ago - Aptorum Group announces collab between DiamiR, Instant NanoBiosensors - TheFly
- 3 months ago - Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease - GlobeNewsWire
- 4 months ago - Aptorum Group files $75M mixed securities shelf - TheFly
- 6 months ago - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference - GlobeNewsWire
- 6 months ago - Aptorum Group files to sell 2.06M Class A ordinary shares for holders - TheFly